We are excited to announce the 10th CNS Partnering & Deal-Making Conference, to be held September 11-12, 2017 in Boston, MA.
Over the years, this partnering and business development conference has provided an opportunity for all stakeholders in the field to network and explore potential collaborations. Global biotechnology and pharmaceutical companies, patient groups and foundations, government agencies, investors, and regulatory folks have gathered to discuss partnering strategies as well as emerging research areas and trends to keep an eye on.
This meeting seeks to form discussion on all topics from bench to bedside, from changing paradigm in scientific approaches in CNS disorders to partnerships for open innovation to pricing and reimbursement considerations. Colleagues will dialogue and form new relationships in order to forge a path forward into the future of neuroscience.
Joint Plenary Sessions:
I. Kick-off Keynote Session – Historical Perspective & State of the Industry
II. Award Ceremony & Closing Keynote Session – Predictions for future
III. Round Table Session: Neuroimaging & Translational Biomarkers
10th CNS Partnering & Deal-making
I. What sells in CNS – New Targets, Models, Assays, etc.
II. Partnering with Academia & CROs to Advance Research
III. CNS Perspectives from Venture Capital & Public Markets
IV. Technology Transfer & Licensing: Challenges & Opportunities
We hope to see you in Boston!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com